Auddia highlights Influence Healthcare's AI-powered, surgeon-led value-based care platform as it prepares to file S-4 merger registration. The model reduces administrativeAuddia highlights Influence Healthcare's AI-powered, surgeon-led value-based care platform as it prepares to file S-4 merger registration. The model reduces administrative

Auddia Highlights Influence Healthcare’s AI-Driven Surgeon-Led Model Ahead of Merger Filing

2026/05/12 18:06
4분 읽기
이 콘텐츠에 대한 의견이나 우려 사항이 있으시면 [email protected]으로 연락주시기 바랍니다

Auddia Inc. (NASDAQ: AUUD) on Tuesday spotlighted Influence Healthcare, a healthtech company that uses artificial intelligence and vertical integration to enable surgeons to lead value-based care (VBC) in high-spend specialties. The announcement comes as Auddia prepares to file its Form S-4 with the Securities and Exchange Commission later this week, a key step in its planned merger with Thramann Holdings LLC.

Influence Healthcare is the third subsidiary, alongside LT350 and Voyex, that will become part of Auddia upon closing of the previously signed definitive merger agreement. The combined entity will be renamed McCarthy Finney, an AI holding company expected to trade under the ticker MCFN.

The company’s model is built on the premise that physicians should lead the healthcare system because they deliver the value. Influence Healthcare organizes surgeons into vertically integrated Value Based Enterprises (VBEs) that contract for bundled case-rate payments in spine, total joint, and other high-cost specialties. These VBEs are supported by advanced AI workflows that automate documentation, coding, episode validation, care-pathway coordination, staffing, supply chain, and logistics, allowing surgeons to focus on clinical care rather than administrative tasks.

“Healthcare is about a physician and patient entering into a relationship to optimize delivery of the highest quality care,” said Jeff Thramann, M.D., CEO of Auddia and Founder of Influence Healthcare, in a statement. “Only the physician has the knowledge, relationship with the patient, and clinical authority to make the many real-time decisions required to deliver the highest quality care at the lowest possible price. Influence Healthcare is aimed at leveraging AI to minimize administrative noise so that physicians and all the other healthcare professionals with hands on patients are empowered to deliver the highest value care.”

Influence Healthcare is intentionally designed as a structural alternative to hospital employment and private-equity rollups, which often reduce physician autonomy or prioritize financial engineering over clinical leadership. Instead, surgeon-led enterprises retain governance authority, episode-based economics flow to clinicians, and facilities participate through aligned partnerships rather than ownership. AI reduces overhead, and surgeons control the clinical pathway.

Post-merger, Influence Healthcare will leverage shared AI services from McCarthy Finney to deploy agentic-AI workflows that automate clinical documentation, coding and billing preparation, episode-of-care validation, prior-authorization workflows, care-pathway adherence monitoring, and communication across the episode. These workflows aim to eliminate administrative layers that have historically required multiple full-time administrative staff per surgeon, contributing to burnout and rising costs.

“AI should not replace physicians, it should replace the administrative friction that prevents physicians from practicing at the top of their license,” Dr. Thramann said. “Our platform gives surgeons the environment they need to deliver a more predictable, coordinated, efficient, and compassionate episode of care.”

The model is designed to deliver lower total cost of care through coordinated episodes, improved outcomes via surgeon-led pathway design, reduced administrative overhead through AI automation, predictable economics for payers and employers, and restored autonomy for surgeons. Influence Healthcare’s initial focus is on spine and total joint surgery, with plans to expand to additional specialties and markets through physician-led VBEs. More information is available at www.influencehealthcare.com.

The merger, announced on February 17, 2026, will combine Auddia with Thramann Holdings, which owns LT350, Influence Healthcare, and Voyex. Upon closing, Auddia will change its name to McCarthy Finney and trade under MCFN. The S-4 filing is expected later this week as the next step in the merger process.

Blockchain Registration, Verification & Enhancement provided by NewsRamp™

This news story relied on content distributed by PRISM Mediawire. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Auddia Highlights Influence Healthcare’s AI-Driven Surgeon-Led Model Ahead of Merger Filing.

The post Auddia Highlights Influence Healthcare’s AI-Driven Surgeon-Led Model Ahead of Merger Filing appeared first on citybuzz.

시장 기회
Gensyn 로고
Gensyn 가격(AI)
$0,0349
$0,0349$0,0349
+0,02%
USD
Gensyn (AI) 실시간 가격 차트
면책 조항: 본 사이트에 재게시된 글들은 공개 플랫폼에서 가져온 것으로 정보 제공 목적으로만 제공됩니다. 이는 반드시 MEXC의 견해를 반영하는 것은 아닙니다. 모든 권리는 원저자에게 있습니다. 제3자의 권리를 침해하는 콘텐츠가 있다고 판단될 경우, [email protected]으로 연락하여 삭제 요청을 해주시기 바랍니다. MEXC는 콘텐츠의 정확성, 완전성 또는 시의적절성에 대해 어떠한 보증도 하지 않으며, 제공된 정보에 기반하여 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다. 본 콘텐츠는 금융, 법률 또는 기타 전문적인 조언을 구성하지 않으며, MEXC의 추천이나 보증으로 간주되어서는 안 됩니다.

No Chart Skills? Still Profit

No Chart Skills? Still ProfitNo Chart Skills? Still Profit

Copy top traders in 3s with auto trading!